1490-44-4

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-6-phenoxypyridazine is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Chloro-6-phenoxypyridazine is utilized as an intermediate in the production of pesticides. Its properties make it suitable for the creation of effective and targeted agrochemicals, enhancing crop protection and management.
Used in Chemical Research and Development:
3-Chloro-6-phenoxypyridazine is also used as a research compound in the field of chemical research and development. Its distinctive structure and reactivity make it a valuable tool for exploring new chemical reactions and syntheses, further expanding the horizons of the chemical industry.

InChI:InChI=1/C10H7ClN2O/c11-9-6-7-10(13-12-9)14-8-4-2-1-3-5-8/h1-7H

Upstream product

• 1677-80-1 3,4-dicholoropyridazine 
• 108-95-2 phenol 
• 141-30-0 3,6-dichlorpyridazine 

Downstream Products

• 10340-55-3 3,6-diphenoxypyridazine 
• 1234349-65-5 2-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzyl]-6-phenoxy-2H-pyridazin-3-one 
• 1231995-30-4 C₂₈H₂₇BN₆O₃ 
• 1231995-31-5 C₂₂H₁₆N₆O₂ 
• 1231995-17-7 C₁₈H₁₃BrN₄O 
• 1231995-18-8 C₂₄H₂₅BN₄O₃ 
• 1231995-05-3 3-{3-[5-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]-benzyl}-6-phenoxy-1,2,4-triazolo[4,3-b]pyridazine 
• 1231994-95-8 6-phenoxy-3-(3-{5-[1-(2-pyrrolidin-1-ylethyl)-1H-pyrazol-4-yl]pyrimidin-2-yl}benzyl)-1,2,4-triazolo[4,3-b]pyridazine 
• 1231994-80-1 3-[3-(5-bromopyrimidin-2-yl)benzyl]-6-phenoxy-1,2,4-triazolo[4,3-b]pyridazine 
• 1788-55-2 6-phenoxypyridazin-3(2H)-one 
• 5639-03-2 3-Phenoxy-pyridazin 

Relevant academic research and scientific papers

Histone deacetylase inhibitor taking pyridazinone as mother nucleus structure, and preparation method and applications thereof

The invention discloses a histone deacetylase inhibitor taking pyridazinone as a mother nucleus structure, and a preparation method and applications thereof. The structure of the inhibitor is shown asa formula I; and the compound shown as the formula I has good histone deacetylase inhibitory activity and anti-tumor cell proliferation effects, and can be used for treating cancers. The structure ofthe inhibitor is shown as the formula I.

PYRIDAZINONE GLUCOKINASE ACTIVATORS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.

3-Quinuclidinyl heteroatom bridged biaryl derivatives

Compounds of formula (I) or a pharmaceutically acceptable salt, amide, or prodrug thereof, wherein: n is 0, 1, or 2; X1 is O, S, —N(R1)—, —N(Ar2)—, and N(R2)C(O)—; Ar1 is a six-membered aromatic ring; Ar2 is cyclohexyl or a mono- or bicyclic aromatic ring, as defined herein. The compounds are useful in treating conditions or disorders prevented by or ameliorated by nAChR ligands. Also disclosed are pharmaceutical compositions having compounds of formula (I) and methods for using such compounds and compositions.

3-Quinuclidinyl heteroatom bridged biaryl derivatives

Compounds of formula: or pharmaceutically acceptable salts, esters, amides, or prodrugs thereof, wherein: A and G are each independently N or N+—O?; m and n are each independently 0, 1, or 2; X1 and X3 are each independently O, S, and —N(R1)—; X2 is O, S, —N(R1)—, —N(Ar2)—, and —N(R2)C(O)—; Ar1 is a six-membered aromatic ring; Ar2 is cyclohexyl or a mono- or bicyclic aromatic ring, and R13 is hydrogen, alkyl, or halogen, as defined herein. The compounds are useful in treating conditions or disorders prevented by or ameliorated by nAChR ligands. Also disclosed are pharmaceutical compositions having compounds of formulas (I) and (II) and methods for using such compounds and compositions.